Select Page

Dengue Vaccine Market studies the virus that causes dengue belongs to the Flavivirus genus of the Flaviviridae family. Dengue fever resembles influenza and affects adults, children, as well as infants, but it is rarely fatal.

Get Sample Copy of this Report @

This report focuses on the Dengue Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

With the increasing population density and global warming, there is a rapid growth in the prevalence of dengue, especially in the tropical and subtropical regions across the world. According to the National Institute of Health, approximately 0.05 to 0.2 billion cases of dengue infections are reported annually and the mortality rate due to dengue was above 20,000.

The report has identified the rapid growth in disease incidences as one of the primary factors that will fuel the growth of the dengue vaccine market in the coming years. The prevalence of dengue is present in more than 125 countries across the world and the rising prevalence of dengue will drive the market during the forecast period.

Global Dengue Vaccine Market is spread across 129 pages, profiling 10 top companies and supported with tables and figures.

Inquire more or share questions if any before the purchase on this report @

The Aedes aegypti mosquito is responsible for transmitting the dengue virus (DENV). However, dengue hemorrhagic fever is a potentially fatal complication because of multiple factors such as fluid accumulation, severe bleeding, organ impairment, or plasma leaking.

The dengue vaccine market is marginally concentrated due to the presence and dominance of the established players. Several companies are investing in R&D to develop more advanced products and expand their product portfolio. Several organizations are merging for research and making enormous efforts to develop vaccines that can challenge the Sanofi Pasteur’s exclusivity in the dengue treatment market. Moreover, several organizations are making huge investments in R&D to develop novel treatment options.

The Americas will be the major revenue contributor to the dengue vaccine market owing to the increasing incidences of dengue cases. The dengue treatment market in the Americas will profit from the bilateral program, Indo-U.S. Vaccine Action Program (VAP), which is concentrated on activities related to immunization and vaccine-related research.

Dengue Vaccine Industry Segment by Manufacturers

  • GlaxoSmithKline
  • Merck Sharp & Dohme
  • Sanofi
  • Takeda Pharmaceuticals
  • GeneOne Life Sciences
  • Medigen Biologics
  • Panacea Biotec
  • Sun Pharmaceutical
  • S NIH
  • Vabiotec

Market Segment by Type covers:

  • DENVax or TAK-003
  • TetraVax-DV
  • V180
  • DNA vaccines

Market Segment by Applications can be divided into:

  • Government institutions
  • Hospitals
  • NGOs

Purchase Report @

There are 15 Chapters to deeply display the Global Dengue Vaccine Market.

Chapter 1: Describe Dengue Vaccine Introduction, product scope, market overview, market opportunities, market risk, and market driving force.

Chapter 2: Analyze the top manufacturers of Dengue Vaccine, with sales, revenue, and price of Dengue Vaccine, in 2015 and 2017.

Chapter 3: Display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2017.

Chapter 4: Show the global market by regions, with sales, revenue and market share of Dengue Vaccine, for each region, from 2011 to 2017.

Chapter 5, 6, 7, 8 and 9: Analyze and talked about the key regions, with sales, revenue and market share by key countries in these regions.

Chapter 10 and 11: Show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2017.

Chapter 12: In Chapter Eleven Dengue Vaccine market forecast, by regions, type and application, with sales and revenue, from 2017 to 2023.

Chapter 13, 14 and 15: Describe Dengue Vaccine sales channel, distributors, traders, dealers, appendix and data source.

About Us

Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the world’s most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

Contact Us:

Ruwin Mendez

Vice President – Global Sales & Partner Relations

Orian Research Consultants

US +1 (415) 830-3727 | UK +44 020 8144-71-27



Follow Us on LinkedIn: